• Wiley Online Library will be disrupted on 18 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance
You have full text access to this OnlineOpen article

Arthritis Care & Research

Copyright © 2013 Wiley-Liss, Inc., A Wiley Company

Cover image for Arthritis Care & Research

June 2010

Volume 62, Issue 6

Pages 747–902

  1. Introduction to Special Section: Drug Safety in the Rheumatic Diseases

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Introduction to Special Section: Drug safety in the rheumatic diseases (pages 747–748)

      Daniel Lovell

      Article first published online: 30 MAR 2010 | DOI: 10.1002/acr.20202

  2. Special Articles

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Safety of tumor necrosis factor α blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti–hepatitis B core antigen positive) with rheumatic diseases (pages 749–754)

      R. Caporali, F. Bobbio-Pallavicini, F. Atzeni, G. Sakellariou, M. Caprioli, C. Montecucco and P. Sarzi-Puttini

      Article first published online: 12 FEB 2010 | DOI: 10.1002/acr.20130

    2. You have full text access to this OnlineOpen article
      Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register (pages 755–763)

      W. G. Dixon, K. D. Watson, M. Lunt, L. K. Mercer, British Society For Rheumatology Biologics Register Control Centre Consortium, K. L. Hyrich and D. P. M. Symmons, British Society for Rheumatology Biologics Register

      Article first published online: 12 FEB 2010 | DOI: 10.1002/acr.20129

    3. You have full text access to this OnlineOpen article
      Neutropenia in patients receiving anti–tumor necrosis factor therapy (pages 764–769)

      Richard Hastings, Tina Ding, Sayqa Butt, Kate Gadsby, Weiya Zhang, Robert J. Moots and Chris Deighton

      Article first published online: 28 MAY 2010 | DOI: 10.1002/acr.20037

    4. You have full text access to this OnlineOpen article
      Trouble with tumor necrosis factor α inhibitors, not just tuberculosis (pages 770–774)

      Tina Racunica, Dermot Cassidy, Flavia Cicuttini and Anthony Hall

      Article first published online: 1 JUN 2010 | DOI: 10.1002/acr.20245

    5. You have full text access to this OnlineOpen article
      Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus (pages 775–784)

      Frederick Wolfe and Michael F. Marmor

      Article first published online: 12 FEB 2010 | DOI: 10.1002/acr.20133

    6. You have full text access to this OnlineOpen article
      Prevention of acute adverse events related to infliximab infusions in pediatric patients (pages 785–790)

      P. Lahdenne, A. M. Wikström, K. Aalto and K. L. Kolho

      Article first published online: 1 JUN 2010 | DOI: 10.1002/acr.20246

    7. You have full text access to this OnlineOpen article
      Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines (pages 791–799)

      Yvonne Nestoriuc, E. John Orav, Matthew H. Liang, Robert Horne and Arthur J. Barsky

      Article first published online: 26 FEB 2010 | DOI: 10.1002/acr.20160

    8. You have full text access to this OnlineOpen article
      Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: Time for a consolidated patient registry (pages 800–804)

      Meredith Y. Smith, Rachel E. Sobel and Carol A. Wallace

      Article first published online: 12 FEB 2010 | DOI: 10.1002/acr.20128

    9. You have full text access to this OnlineOpen article
      Avoiding common pitfalls in the analysis of observational studies of new treatments for rheumatoid arthritis (pages 805–810)

      Marie Hudson and Samy Suissa

      Article first published online: 9 FEB 2010 | DOI: 10.1002/acr.20124

  3. Pediatric Rheumatology

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Toward the development of criteria for global flares in juvenile systemic lupus erythematosus (pages 811–820)

      Hermine I. Brunner, Marisa S. Klein-Gitelman, Gloria C. Higgins, Sivia K. Lapidus, Deborah M. Levy, Anne Eberhard, Nora Singer, Judyann C. Olson, Karen Onel, Marilynn Punaro, Laura Schanberg, Emily von Scheven, Jun Ying and Edward H. Giannini

      Article first published online: 9 FEB 2010 | DOI: 10.1002/acr.20126

    2. You have full text access to this OnlineOpen article
      Abatacept for severe anti–tumor necrosis factor α refractory juvenile idiopathic arthritis–related uveitis (pages 821–825)

      Francesco Zulian, Marta Balzarin, Fernanda Falcini, Giorgia Martini, Maria Alessio, Rolando Cimaz, Luca Cimino and Maria Elisabetta Zannin

      Article first published online: 29 JAN 2010 | DOI: 10.1002/acr.20115

  4. Ankylosing Spondylitis

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Thresholds of patient-reported outcomes that define the patient acceptable symptom state in ankylosing spondylitis vary over time and by treatment and patient characteristics (pages 826–834)

      Walter P. Maksymowych, Katherine Gooch, Maxime Dougados, Robert L. Wong, Naijun Chen, Hartmut Kupper and Désirée van der Heijde

      Article first published online: 12 FEB 2010 | DOI: 10.1002/acr.20131

  5. Giant Cell Arteritis

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin-6) in the long-term followup of patients with giant cell arteritis (pages 835–841)

      Ana García-Martínez, José Hernández-Rodríguez, Georgina Espígol-Frigolé, Sergio Prieto-González, Montserrat Butjosa, Marta Segarra, Ester Lozano and Maria C. Cid

      Article first published online: 28 MAY 2010 | DOI: 10.1002/acr.20043

  6. Rheumatoid Arthritis

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: Results from a choice-based conjoint analysis (pages 842–847)

      Wietske Kievit, Laura van Hulst, Piet van Riel and Liana Fraenkel

      Article first published online: 9 FEB 2010 | DOI: 10.1002/acr.20123

    2. You have full text access to this OnlineOpen article
      Disease severity and domain-specific arthritis self-efficacy: Relationships to pain and functioning in patients with rheumatoid arthritis (pages 848–856)

      Tamara J. Somers, Rebecca A. Shelby, Francis J. Keefe, Neha Godiwala, Mark A. Lumley, Angelia Mosley-Williams, John R. Rice and David Caldwell

      Article first published online: 12 FEB 2010 | DOI: 10.1002/acr.20127

    3. You have full text access to this OnlineOpen article
      Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis (pages 857–864)

      Jennifer L. Barton, John Imboden, Jonathan Graf, David Glidden, Edward H. Yelin and Dean Schillinger

      Article first published online: 12 FEB 2010 | DOI: 10.1002/acr.20132

    4. You have full text access to this OnlineOpen article
      Exploring the public health impact of an intensive exercise program for patients with rheumatoid arthritis: A dissemination and implementation study (pages 865–872)

      F. J. van der Giesen, W. van Lankveld, M. Hopman-Rock, Z. de Jong, M. Munneke, J. M. W. Hazes, P. L. C. M. van Riel, A. J. Peeters, H. K. Ronday and T. P. M. Vliet Vlieland

      Article first published online: 23 FEB 2010 | DOI: 10.1002/acr.20138

  7. Systemic Lupus Erythematosus

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Long-term mortality and renal outcome in a cohort of 100 patients with Lupus Nephritis (pages 873–880)

      Mikkel Faurschou, Lene Dreyer, Anne-Lise Kamper, Henrik Starklint and Søren Jacobsen

      Article first published online: 29 JAN 2010 | DOI: 10.1002/acr.20116

    2. You have full text access to this OnlineOpen article
      Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus (pages 881–887)

      M. B. Urowitz, D. Gladman, D. Ibañez, S. C. Bae, J. Sanchez-Guerrero, C. Gordon, A. Clarke, S. Bernatsky, P. R. Fortin, J. G. Hanly, D. J. Wallace, D. Isenberg, A. Rahman, G. S. Alarcón, J. T. Merrill, E. Ginzler, M. Khamashta, O. Nived, G. Sturfelt, I. N. Bruce, K. Steinsson, S. Manzi, R. Ramsey-Goldman, M. A. Dooley, A. Zoma, K. Kalunian, M. Ramos, R. F. Van Vollenhoven, C. Aranow, T. Stoll, M. Petri and P. Maddison, Systemic Lupus International Collaborating Clinics

      Article first published online: 9 FEB 2010 | DOI: 10.1002/acr.20122

    3. You have full text access to this OnlineOpen article
      Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus (pages 888–895)

      Chris Tonner, Laura Trupin, Jinoos Yazdany, Lindsey Criswell, Patricia Katz and Edward Yelin

      Article first published online: 9 FEB 2010 | DOI: 10.1002/acr.20125

  8. Contribution from the Field

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Yellow fever revaccination during infliximab therapy (pages 896–898)

      Morton Scheinberg, Luis Sergio Guedes-Barbosa, Cristovao Mangueira, Eliane Aparecida Rosseto, Licia Mota, Ana Cristina Oliveira and Rodrigo Aires Lima

      Article first published online: 1 JUN 2010 | DOI: 10.1002/acr.20045

  9. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Submissions invited for themed issue of Arthritis Care & Research: Vascular comorbidity in the rheumatic diseases (page 898)

      Article first published online: 1 JUN 2010 | DOI: 10.1002/acr.20259

  10. Letters

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Low incidence of flare and persistent active disease in a cohort of Italian patients with systemic lupus erythematosus: Comment on the article by Nikpour et al (pages 899–900)

      Fabrizio Conti, Fulvia Ceccarelli, Carlo Perricone, Laura Massaro, Francesca Romana Spinelli and Guido Valesini

      Article first published online: 23 FEB 2010 | DOI: 10.1002/acr.20145

  11. Reply

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Reply (page 900)

      Mandana Nikpour, Murray B. Urowitz, Dominique Ibañez and Dafna D. Gladman

      Article first published online: 23 FEB 2010 | DOI: 10.1002/acr.20157

  12. Letters

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Systematic review of shoulder function questionnaires: Comment on the article by Roy et al (pages 900–901)

      Roberto Padua, Alex Castagna, Federica Alviti and Luca Padua

      Article first published online: 29 JAN 2010 | DOI: 10.1002/acr.20113

  13. Reply

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Reply (page 901)

      Jean-Sébastien Roy, Joy C. MacDermid and Linda J. Woodhouse

      Article first published online: 29 JAN 2010 | DOI: 10.1002/acr.20121

  14. Letters

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have full text access to this OnlineOpen article
      Antidepressants as an often overlooked therapeutic option for the treatment and management of arthritis pain: Comment on the article by Wolfe and Michaud (pages 901–902)

      Shailendra Kapoor

      Article first published online: 19 FEB 2010 | DOI: 10.1002/acr.20120

    2. You have full text access to this OnlineOpen article
      Association between the use of serotonin receptor 2A–blocking antidepressants and joint disorders: Comment on the article by Kling et al (page 902)

      Michael Pazianas

      Article first published online: 12 FEB 2010 | DOI: 10.1002/acr.20134

  15. ARHP Announcements

    1. Top of page
    2. Introduction to Special Section: Drug Safety in the Rheumatic Diseases
    3. Special Articles
    4. Pediatric Rheumatology
    5. Ankylosing Spondylitis
    6. Giant Cell Arteritis
    7. Rheumatoid Arthritis
    8. Systemic Lupus Erythematosus
    9. Contribution from the Field
    10. Submissions Invited for Themed Issue of Arthritis Care & Research: Vascular Comorbidity in the Rheumatic Diseases
    11. Letters
    12. Reply
    13. Letters
    14. Reply
    15. Letters
    16. ARHP Announcements
    1. You have free access to this content
      ARHP announcements

      Article first published online: 1 JUN 2010 | DOI: 10.1002/acr.20266

SEARCH

SEARCH BY CITATION